chr6-151807928-C-T

Variant summary

Our verdict is Benign. The variant received -9 ACMG points: 0P and 9B. BP4_StrongBP6BS2

The NM_000125.4(ESR1):​c.16C>T​(p.His6Tyr) variant causes a missense change. The variant allele was found at a frequency of 0.0045 in 1,613,882 control chromosomes in the GnomAD database, including 24 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Synonymous variant affecting the same amino acid position (i.e. H6H) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.0031 ( 1 hom., cov: 32)
Exomes 𝑓: 0.0046 ( 23 hom. )

Consequence

ESR1
NM_000125.4 missense

Scores

5
8
6

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:3

Conservation

PhyloP100: 3.94
Variant links:
Genes affected
ESR1 (HGNC:3467): (estrogen receptor 1) This gene encodes an estrogen receptor and ligand-activated transcription factor. The canonical protein contains an N-terminal ligand-independent transactivation domain, a central DNA binding domain, a hinge domain, and a C-terminal ligand-dependent transactivation domain. The protein localizes to the nucleus where it may form either a homodimer or a heterodimer with estrogen receptor 2. The protein encoded by this gene regulates the transcription of many estrogen-inducible genes that play a role in growth, metabolism, sexual development, gestation, and other reproductive functions and is expressed in many non-reproductive tissues. The receptor encoded by this gene plays a key role in breast cancer, endometrial cancer, and osteoporosis. This gene is reported to have dozens of transcript variants due to the use of alternate promoters and alternative splicing, however, the full-length nature of many of these variants remain uncertain. [provided by RefSeq, Jul 2020]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -9 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.012596518).
BP6
Variant 6-151807928-C-T is Benign according to our data. Variant chr6-151807928-C-T is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 712708.We mark this variant Likely_benign, oryginal submissions are: {Uncertain_significance=1, Likely_benign=2}.
BS2
High Homozygotes in GnomAdExome4 at 23 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ESR1NM_000125.4 linkc.16C>T p.His6Tyr missense_variant Exon 1 of 8 ENST00000206249.8 NP_000116.2 P03372-1G4XH65

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ESR1ENST00000206249.8 linkc.16C>T p.His6Tyr missense_variant Exon 1 of 8 1 NM_000125.4 ENSP00000206249.3 P03372-1

Frequencies

GnomAD3 genomes
AF:
0.00309
AC:
470
AN:
152198
Hom.:
1
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000724
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00157
Gnomad ASJ
AF:
0.00346
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00166
Gnomad FIN
AF:
0.00348
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00519
Gnomad OTH
AF:
0.00287
GnomAD2 exomes
AF:
0.00327
AC:
811
AN:
248082
AF XY:
0.00323
show subpopulations
Gnomad AFR exome
AF:
0.000746
Gnomad AMR exome
AF:
0.000898
Gnomad ASJ exome
AF:
0.00428
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00431
Gnomad NFE exome
AF:
0.00515
Gnomad OTH exome
AF:
0.00360
GnomAD4 exome
AF:
0.00465
AC:
6791
AN:
1461566
Hom.:
23
Cov.:
30
AF XY:
0.00449
AC XY:
3266
AN XY:
727092
show subpopulations
Gnomad4 AFR exome
AF:
0.000568
AC:
19
AN:
33476
Gnomad4 AMR exome
AF:
0.000872
AC:
39
AN:
44718
Gnomad4 ASJ exome
AF:
0.00390
AC:
102
AN:
26130
Gnomad4 EAS exome
AF:
0.00
AC:
0
AN:
39690
Gnomad4 SAS exome
AF:
0.00134
AC:
116
AN:
86246
Gnomad4 FIN exome
AF:
0.00443
AC:
236
AN:
53252
Gnomad4 NFE exome
AF:
0.00534
AC:
5942
AN:
1111900
Gnomad4 Remaining exome
AF:
0.00543
AC:
328
AN:
60386
Heterozygous variant carriers
0
355
710
1064
1419
1774
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Exome Het
Exome Hom
Variant carriers
0
220
440
660
880
1100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00308
AC:
469
AN:
152316
Hom.:
1
Cov.:
32
AF XY:
0.00273
AC XY:
203
AN XY:
74468
show subpopulations
Gnomad4 AFR
AF:
0.000722
AC:
0.000721501
AN:
0.000721501
Gnomad4 AMR
AF:
0.00157
AC:
0.00156822
AN:
0.00156822
Gnomad4 ASJ
AF:
0.00346
AC:
0.00345622
AN:
0.00345622
Gnomad4 EAS
AF:
0.00
AC:
0
AN:
0
Gnomad4 SAS
AF:
0.00166
AC:
0.001657
AN:
0.001657
Gnomad4 FIN
AF:
0.00348
AC:
0.00348268
AN:
0.00348268
Gnomad4 NFE
AF:
0.00517
AC:
0.00517434
AN:
0.00517434
Gnomad4 OTH
AF:
0.00284
AC:
0.00284091
AN:
0.00284091
Heterozygous variant carriers
0
22
43
65
86
108
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Genome Het
Genome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00437
Hom.:
4
Bravo
AF:
0.00273
TwinsUK
AF:
0.00458
AC:
17
ALSPAC
AF:
0.00493
AC:
19
ESP6500AA
AF:
0.000681
AC:
3
ESP6500EA
AF:
0.00512
AC:
44
ExAC
AF:
0.00348
AC:
422
EpiCase
AF:
0.00529
EpiControl
AF:
0.00534

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:3
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Uncertain:1Benign:2
Mar 01, 2024
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

ESR1: PP3, BS2 -

Dec 16, 2024
GeneDx
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Identified in an individual with primary ovarian insufficiency, however, functional studies in HEK293T cells demonstrated that the variant showed similar transcriptional activity to wild type (PMID: 27603904); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 23074960, 27603904, 34662886, 36099812) -

Dec 31, 2019
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

ESR1-related disorder Benign:1
Jun 27, 2019
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.18
BayesDel_addAF
Benign
-0.13
T
BayesDel_noAF
Uncertain
0.050
CADD
Uncertain
24
DANN
Uncertain
1.0
DEOGEN2
Benign
0.40
T;T;T;T;T;T;T;T
Eigen
Uncertain
0.51
Eigen_PC
Uncertain
0.45
FATHMM_MKL
Uncertain
0.83
D
LIST_S2
Pathogenic
0.97
D;.;.;D;D;.;D;D
M_CAP
Pathogenic
0.43
D
MetaRNN
Benign
0.013
T;T;T;T;T;T;T;T
MetaSVM
Pathogenic
0.84
D
MutationAssessor
Benign
0.63
.;N;N;.;N;N;.;.
PrimateAI
Pathogenic
0.83
D
PROVEAN
Uncertain
-3.0
D;N;N;D;N;N;N;N
REVEL
Uncertain
0.49
Sift
Uncertain
0.0010
D;D;D;T;D;D;D;D
Sift4G
Pathogenic
0.0
D;T;T;D;T;T;D;D
Polyphen
0.99, 1.0
.;D;D;.;D;D;D;.
Vest4
0.56, 0.56, 0.55, 0.52, 0.30, 0.40
MVP
0.80
MPC
1.3
ClinPred
0.047
T
GERP RS
5.2
Varity_R
0.16
gMVP
0.74
Mutation Taster
=94/6
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs139960913; hg19: chr6-152129063; COSMIC: COSV52793297; COSMIC: COSV52793297; API